Search Results - "T. A. Kumova"

Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome by I. N. Medvedev, T. A. Kumova

“…The authors compared platelet hemostasis effects for two angiotensin receptor blockers, valsartan and eprosartan, in patients with arterial hypertension (AH)…”
Get full text

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom by I. N. Medvedev, T. A. Kumova

“…То assess angiotensin II receptor blocker effects on platelet aggregation in arterial hypertension (AH) and metabolic syndrome (MS), 34 patients were…”
Get full text

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome by I. N. Medvedev, T. A. Kumova

“…To assess the angiotensin II blocker effects on platelet (PL) aggregation in patients with arterial hypertension (AH) and metabolic syndrome (MS). In total, 35…”
Get full text

Rapid normalization of platelet hemostasis in patients with arterial hypertension and metabolic syndrome by I. N. Medvedev, A. V. Plotnikov, T. A. Kumova

“…The study aimed at identifying rapid methods of platelet (PL) hemostasis normalization in patients with arterial hypertension (AH) and metabolic syndrome (MS)…”
Get full text

Effect of eprosartan on thrombocytes aggregative capacity in patients with arterial hypertension and metabolic syndrome by Simonenko, V B, Medvedev, I N, Kumova, T A

“…The influence of angiotensin II blocker in thrombocytes aggregative capacity in patients with arterial hypertension and metabolic syndrome was assessed. 32…”
Get more information

Angiotensin II receptor inhibitors: role and place in arterial hypertension and metabolic syndrome treatment by I. N. Medvedev, T. A. Kumova

Get full text

Losartan for the correction of thrombocyte activity in patients suffering from arterial hypertension with metabolic syndrome by Simonenko, V B, medvedev, i N, Kumova, T A

“…The aim of the study was to evaluate therapeutic effects of losartan on intravascular thrombocyte activity (ITA) in patients suffering from arterial…”
Get more information

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome by I. N. Medvedev, T. A. Kumova

“…Aim: To study therapeutic effects of eprosartan on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome…”
Get full text

RENIN-ANGIOTENSIN SYSTEM ROLE IN ARTERIAL HYPERTENSION DEVELOPMENT by I. N. Medvedev, T. A. Kumova, O. V. Gamolina

Get full text

METHODOLOGY OF BLOOD RHEOLOGY ASSESSMENT IN VARIOUS CLINICAL SITUATIONS by I. N. Medvedev, A. P. Savchenko, S. Yu. Zavalishina, E. G. Krasnova, T. A. Kumova, O. V. Gamolina, I. A. Skoryakina, T. S. Fadeeva

Get full text

Pathogenetic aspects of hypertension in case of metabolic syndrome by Simonenko, V B, Medvedev, I N, Kumova, T A

“…Hypertension is the main disease in Russian Federation--its frequency is 39.2% in men and 41.1% in women. In recent years course of a disease is accompanied by…”
Get more information